CORRECTION article

Front. Oncol., 15 October 2021

Sec. Molecular and Cellular Oncology

Volume 11 - 2021 | https://doi.org/10.3389/fonc.2021.785394

Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma

  • 1. State Key Laboratory of Pathogenesis, Prevention, and Treatment of Central Asian High Incidence Diseases, Clinical Medical Research Institute, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

  • 2. Graduate Academy, Xinjiang Medical University, Urumqi, China

  • 3. Department of Clinical Laboratory, The First Affiliated Hospital of Xinjiang Medical University, Urumqi, China

  • 4. College of Pharmacy, Xinjiang Medical University, Urumqi, China

In the original article, there was a mistake in Figure 6G as published. The label of Figure 6G should be HUH7 instead of HUH7-p65. The corrected Figure 6 appears below.

In the original article, there was a mistake in Figure 7 E, F as published. During the last round of revisions, we uploaded the wrong version of the file, resulting in a complete repetition of images E, F and C, D. “E, F” should have been the result of the HUH7 cell line. The corrected Figure 7 appears below.

Figure 6

Figure 7

The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Publisher’s Note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Summary

Keywords

hepatocellular carcinoma, LINC01667, diagnostic biomarker, overall survival, carcinogenesis

Citation

Zhang K, Liu H, Yu M, Zhao H, Yang N, Bi X, Sun L, Lin R and Lü G (2021) Corrigendum: Upregulated LINC01667 Expression Is Correlated With Poor Prognosis in Hepatocellular Carcinoma. Front. Oncol. 11:785394. doi: 10.3389/fonc.2021.785394

Received

29 September 2021

Accepted

30 September 2021

Published

15 October 2021

Volume

11 - 2021

Edited and reviewed by

Fei-Ting Hsu, China Medical University, Taiwan

Updates

Copyright

*Correspondence: Guodong Lü, ; Renyong Lin,

†These authors have contributed equally to this work and share first authorship

This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Outline

Figures

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics